Skip to content
TheNote.app
Download_on_the_App_Store_Badge_US-UK_RGB_blk_4SVG_092917
FDA | What's New
Drug Trials Snapshot: FABHLATA
Follow
FABHALTA is a prescription drug that is a complement factor B inhibitor, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).
fda.gov
fda.gov